Written answer
Medicinal Products
862. Deputy Jen Cummins asked the Minister for Health the immediate steps being taken to stabilise the supply of lenzetto in pharmacies; and the protocols being introduced to ensure that when critical shortages occur, alternative options such imported stocks are fully available and accessible without compromising patient care. [78813/26]
Comment on this
The Department is aware of the stress that medicine shortages can cause for patients and healthcare professionals. Managing and mitigating medicine shortages is a priority for the Department of Health and is the subject of several workstreams across the Department and the wider health service.
Under European and national medicines legislation, pharmaceutical companies and wholesalers are required to ensure an appropriate and continuous supply of the medicines they place on the market. Companies are also required to notify the Health Products Regulatory Authority (HPRA) of actual or anticipated shortages affecting the Irish market. The HPRA maintains a publicly available list of current and resolved medicine shortages and works closely with suppliers to minimise the duration and impact of shortages on patients.
All shortages, including persistent shortages, are managed via the national Medicines Shortages Framework (MSF), which is coordinated by the HPRA. The MSF involves a multi-stakeholder approach to handling shortages of human medicinal products. Where required, the HPRA engages with all relevant stakeholders to support continuity of care until sufficient supply of the medicinal product is available to meet demand.
According to the HPRA shortages database, there is currently a shortage affecting Lenzetto 1.53 mg/spray Transdermal Spray, Solution. The shortage is attributed to unexpected increased demand across multiple countries. The expected return date is currently listed as 9 November 2026. The HPRA shortages database has also indicated that an appropriate authorised alternative medicine is available.
Patients who are experiencing difficulty obtaining their prescribed medication should consult their healthcare professional, such as their GP or pharmacist, regarding alternative treatment options.